Skip to content

Dr. Ine Van Bogaert

Active
Private limited companyfounded 2023active for 3 yearsGrensstraat(MD) 20, 9170 Sint-Gillis-Waas, BelgiumKBO/BCE: BE 1000.695.946
Summary

Dr. Ine Van Bogaert has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €108,093 and a net result of €43,714. Its solvency ranks better than 40% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 03-10-2023 Normal situation
Activity
General medical practice NACE 86210and 1 other
Establishment unit
2.350.710.668 9170 Sint-Gillis-Waas, since 03-10-2023
Financial year end
31 December
Peppol
Reachable since 14-10-2025

Board and ownership

Board

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€64,834
▼ 16.3%
Turnover
≈ €150,000
estimated
Profit
€43,714
▼ 26.4%
Equity
€108,093
▲ 67.9%
Total assets
€209,608
▲ 192%
Filed on 07-07-2026, 24 days before the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 4.70, cash €93,331Figures for financial year 2025 (filed on 07-07-2026)Equity €108,093 (51.6% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 69% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 77-23
equity 51.6% of total assets
Liquidity 100=
short-term debt 9.9% · cash 44.5%
Profitability 95-5
return on assets 20.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: 0.3% 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.4%▲ +0.1 percentage points vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025highest value 06-2025: < 0.1%▼ -0.4 percentage points vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025lowest value 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €10,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.7 (9.08 in 2024), above the usual 1.5. Short-term debt is 9.9% and cash 44.5% of total assets. 48.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 41% of them on solvency, 95% on liquidity, 53% on profitability and 85% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 4.70, cash €93,331
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 07-07-2026)
NBB · annual accounts
lowers risk · Equity €108,093 (51.6% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
24 days early
2024
72 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 48 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Recent changes

  1. · Gazette deed IncorporationAppointment: VAN BOGAERT Ine Josephina Gustaaf (director)
All 4 events

Comparable companies

These companies have the same main activity as Dr. Ine Van Bogaert: general medical practice (NACE 86210). They are comparable in size and age: total assets between €185,000 and €230,000, founded between 2023 and 2024.

CompanyTotal assetsGross margin
Dr. Ine Van Bogaert Sint-Gillis-Waas€209,608€64,834
HAVALO Kinrooi€197,270€65,727
Docteur RIKIR Anne-France Herve€210,328€67,385
Dr. Govarts Anouk Scherpenheuvel-Zichem€184,986€67,243
BELVEMED Soumagne€218,116€67,875
Dokter Elke Moortgat Huisarts Rumst€230,243€60,823
Dr. Souffriau Nele Haaltert€184,770€63,833
Full comparison

Key facts about Dr. Ine Van Bogaert

What is the company number of Dr. Ine Van Bogaert?
The company number of Dr. Ine Van Bogaert is 1000.695.946. The VAT number is the same number with BE in front: BE 1000.695.946.
Where is Dr. Ine Van Bogaert based?
The registered office is at Grensstraat(MD) 20, 9170 Sint-Gillis-Waas.Company details
What does Dr. Ine Van Bogaert do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Ine Van Bogaert?
The legal form of Dr. Ine Van Bogaert is Private limited company (BV).
When was Dr. Ine Van Bogaert founded?
Dr. Ine Van Bogaert was founded on 03-10-2023.
Is Dr. Ine Van Bogaert still active?
Yes, Dr. Ine Van Bogaert is an active enterprise in the KBO register.
What is the turnover of Dr. Ine Van Bogaert?
The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €64,834 and 32 comparable companies (NACE 862). It probably lies between €110,000 and €190,000.Financials
Is Dr. Ine Van Bogaert profitable?
In financial year 2025, Dr. Ine Van Bogaert made a profit of €43,714.
Where can I find the annual accounts of Dr. Ine Van Bogaert?
Dr. Ine Van Bogaert filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Ine Van Bogaert due?
Dr. Ine Van Bogaert must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.